Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy
Frederick Health Hospital Faces 5 Lawsuits Following Ransomware Attack
Arkansas Methodist Medical Center and Baptist Memorial Health Care to Merge
Ground Broken on Intermountain Saratoga Springs Multi-Specialty Clinic
Electrical Fire Tests Resilience of Massachusetts Hospital